Literature DB >> 6728897

Differential effects of isoniazid and oral contraceptive steroids on antipyrine oxidation and acetaminophen conjugation.

H R Ochs, D J Greenblatt, B Verburg-Ochs, D R Abernethy, M Knüchel.   

Abstract

Factors influencing hepatic oxidation of antipyrine and conjugation of acetaminophen were evaluated in volunteers who received 1.0 g of antipyrine intravenously and on a different occasion a 650 mg intravenous dose of acetaminophen. In study one, subjects received both drugs in the control state and at another time during coadministration of isoniazid (INH), 180 mg daily. In control versus INH conditions, mean clearance of antipyrine was reduced from 0.67 to 0.60 ml/min/kg as was clearance of acetaminophen from 4.97 to 4.23 ml/min/kg, but these differences were not statistically significant. In study two, females on low-dose estrogen oral contraceptives (OC) and drug-free controls matched for age received both drugs. Compared to controls, OC users had reduced total clearance of antipyrine (0.71 vs. 0.50 ml/min/kg; p less than 0.005) and prolonged antipyrine t1/2 (9.6 vs. 13.3 h; p less than 0.005). For acetaminophen, however, OC users had higher clearance (5.2 vs. 6.1 ml/min/kg) and shorter t1/2 (2.2 vs. 1.9 h) although differences did not attain statistical significance. Clearance of antipyrine and acetaminophen across both studies was not statistically significantly correlated within individuals (r = 0.22). The capacities for drug oxidation and conjugation appear to be controlled by different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6728897     DOI: 10.1159/000137961

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  6 in total

1.  Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon.

Authors:  H Mönig; C Baese; H T Heidemann; E E Ohnhaus; H M Schulte
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

2.  Acetaminophen pharmacokinetics in women receiving conjugated estrogen.

Authors:  J M Scavone; D J Greenblatt; G T Blyden; B G Luna; J S Harmatz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Inhibition of the metabolism of paracetamol by isoniazid.

Authors:  M M Epstein; S D Nelson; J T Slattery; T F Kalhorn; R A Wall; J M Wright
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

4.  Pharmacokinetics of oxaprozin in women receiving conjugated estrogen.

Authors:  J M Scavone; H R Ochs; D J Greenblatt; R Matlis
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen.

Authors:  Yanli Zhao; Jerold S Harmatz; Carol R Epstein; Yukako Nakagawa; Chie Kurosaki; Tetsuro Nakamura; Takumi Kadota; Dennis Giesing; Michael H Court; David J Greenblatt
Journal:  Br J Clin Pharmacol       Date:  2015-06-08       Impact factor: 4.335

6.  Paracetamol pharmacokinetics and metabolism in young women.

Authors:  Karel Allegaert; Mariska Y Peeters; Bjorn Beleyn; Anne Smits; Aida Kulo; Kristel van Calsteren; Jan Deprest; Jan de Hoon; Catherijne A J Knibbe
Journal:  BMC Anesthesiol       Date:  2015-11-13       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.